Malignant Ovarian Serous Tumor
3 clinical trials · Condition
◉ Watch Malignant Ovarian Serous Tumor
| Record | Firm | Date |
|---|---|---|
| Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02569957) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-10-02 |
| Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent (NCT02470559) | Barbara Ann Karmanos Cancer Institute | 2015-06-01 |
| YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy (NCT00899093) | Gynecologic Oncology Group | 2007-09-01 |
Track Malignant Ovarian Serous Tumor automatically
Every clearance here is in the API, with alerts when new ones post.